I have Type 1 diabetes. I love to write. I’m happy when I am helping others. I speak up when it’s important. I have a passion for sharing knowledge and learning new technology. I was BORN to BLOG!
I’ve met so many other T1Ds on this journey who are cool and love to help others. We put our heads and hearts together … to bring more resources and knowledge to our amazing diabetes community. We’re making improvements every day … come back often, let us know what you think. And my gratitude for my amazing webmaster, Dave (an honorary T1D)!
And thank you for stopping by!
— Joanne Laufer Milo, The Savvy Diabetic
Savvy Eating/Gut, 8/17/22: Gut Microbiome & T1D, Monk Fruit as Prebiotic Sweetener, Mental Fatigue & T1D
All About your Gut Microbiome was shared by Marissa Town for ChildrenWithDiabetes.com, 10 August 2022. The onset of type 1 diabetes and other autoimmune illnesses typically involves some environmental trigger combined with a genetic risk. Some researchers...
Savvy Updates 8/15/22: Comments on CGM Alarms to FDA DEADLINE 8/15/2022, Inflation Reduction Act Becomes Law, Glucagon Emergency Kit Discontinued, Sensor Jewelry, Dr. Francine Kaufman on Senseonics, Omnipod 5 vs. Tandem Diabetes, Monkey Pox & T1D
Final Day: Make Your Voice Heard AGAIN to the FDA re CGM! Here’s another chance to tell them, in a few short sentences, what you want, regarding CGM (continuous glucose monitoring) alarms! The FDA has mandated that CGM LOW BG alarms MAY NOT be turned off or...
Savvy Advocacy, 8/10/22: Make your Voice Heard AGAIN to the FDA re CGM!
From one of the founders of the #WeAreNotWaiting" movement: "Hey FDA, if you had been listening to us, we wouldn't have had to overwhelm you with public comments!" This is about the Fulfillment of 21st Century Cures Act Section 3060 Required Report: Comments...
Savvy Updates 8/8/22: D Business/Earnings (Tandem, Insulet, Dexcom), Senseonics/Eversense E3 Covered by Anthem, Go to Sleep Before Midnight
Tandem lines up FDA review of new pint-sized insulin pump amid lower-than-expected sales was reported by Andrea Park for FierceBioTech.com, 4 August 2022. After stumbling a bit in the second quarter of the year, Tandem Diabetes is getting back on its feet,...
Savvy Eating, 8/3/22: Love Cheese? Ayurveda Indian Medicine, Yogurts for T1Ds
Love cheese? Thank your ancestors. They were eating dairy thousands of years before they could digest it was posted by Jason Goodyer for ScienceFocus.com, 29 July 2022. A study carried out by scientists from the University of Bristol and University College...
Savvy Updates 8/1/22: Dexcom G7 DELAYED, Immune System May Not Be Cause of T1D, Abvance Therapeutics Insulin/Glucagon
Dexcom to resubmit G7 glucose monitor software for FDA review, pushing back US launch was posted by Conor Hale for FierceBioTech.Com, 29 July 2022. Diabetes tracker developer Dexcom is pushing back the timeline for a U.S. launch of the latest generation of its...
Savvy Updates, 7/25/22: GSK-126 Restores Beta Cells, SpaceX Grows Stem Cells, Trigger Finger/Carpal Tunnel Gene Variant, UnitedHealthcare $0 Insulin CoPay Only Will Affect Few, POGO BG Meter UPDATE
Experimental drug may help restore insulin-producing cells was written by Clarissa Brincat for MedicalNewsToday.com, 22 July 2022. In a recent study, the human epigenetics team at Monash University in Melbourne, Australia, found that the investigational drug GSK-126...
Savvy Travel Tips: Traveling with Diabetes from TCOYD
TCOYD: Taking Care of Your Diabetes with Drs. Steve Edelman and Jeremy Pettus. Learn and giggle some too! Learn some travel tips from these type 1 diabetes jet setters before setting out on your next worldwide adventure, or even just for your next staycation....
Savvy Updates, 7/18/22: Power of YOUR VOICES to the US FDA, Timely Access to Care Act, About Chocolate
Diabetes Patients Flood FDA with Comments on Cybersecurity for Medical Devices, as reported by Mariam Baksh for NextGov.com, 8 July 2022. The Food and Drug Administration received more than a thousand comments—mainly from diabetes patients and their family...
Savvy Updates, 7/11/22: Vertex Resumes Testing, US Senate Dems Move to Lower Drug Prices, Potatoes Better with Vinegar, Sugar Cravings Reduce by New Gum
Vertex, continuing its rebound, cleared to resume testing of diabetes cell therapy was written by Ben Fidler for BioPharmaDive.com, 6 July 2022. The Food and Drug Administration has cleared Vertex Pharmaceuticals to resume a study evaluating an...
More Diabetes Blogs